Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: Implications for Parkinson's disease

Journal of Pineal Research

Volumn 24, Issue 3, 1998, Pages 179-192

  Mayo, Juan Carlos ^a   Sainz, Rosa Maria ^a   Uria, Higinio ^a   Antolin, Isaac ^c   Esteban, Manuel M ^a   Rodriguez, Carmen ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

^c NONE

Author keywords

6 OHDA; Antioxidant enzymes mRNA; Apoptosis; Melatonin; Parkinson's disease; PC12 cells

Indexed keywords

ANTIOXIDANT; DNA FRAGMENT; MELATONIN; MESSENGER RNA; NEUROPROTECTIVE AGENT; OXIDOPAMINE;

APOPTOSIS; ARTICLE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL; PARKINSON DISEASE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DNA FRAGMENTATION; MELATONIN; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; PC12 CELLS; RATS; SYMPATHOLYTICS;

EID: 0031981649     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1998.tb00531.x     Document Type: Article

References (85)

1. ABE, M., R.J. REITER, P.H. ORHII, M. HARA, B. POEGGELER, L.C. MANCHESTER, L. BARLOW-WALDEN (1994) Inhibitory effect of melatonin on cataract formation in newborn rats: Evidence of an antioxidative role for melatonin. J. Pineal Res. 17:94-100.
2. ACUÑA-CASTROVIEJO, D., A. COTO-MONTES, G. MONTI, G.G. ORTIZ, R.J. REITER (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci. 60:23-29.
3. ANTOLÍN, I., C. RODRIGUEZ, R.M. SAINZ, J.C. MAYO, H. URÍA, M. KOTLER, M.J. RODRÍGUEZ-COLUNGA, D. TOLIVIA, A. MENENDEZ-PELAEZ (1996) Neurohormone melatonin prevents cell damage: Effect on gene expression for antioxidant enzymes. FASEB J. 10:882-890.
4. BARLOW-WALDEN, L., R.J. REITER, M. ABE, M.I. PABLOS, A. MENENDEZ-PELAEZ, L.D. CHEN, B. POEGGELER (1995) Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26:497-502.
5. BEHL, C., F. LEZOUALC'H, T. TRAPP, M. WIDMANN, T. SKUTELLA, F. HOLSBOER (1997) Glucocorticoids enhance oxidative stress-induced cell death in hipocampal neurons in vitro. Endocrinology 138:101-106.
6. BEN-SACHAR, D., G. ESHEL, P. RIEDERER, M.B. YOUDIM (1992) Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease. Ann. Neurol. 32:5105-110.
7. BENITEZ-KING, G., L. HUERTA DELGADILLO, F. ANTON TAY (1991) Melatonin modifies calmodulin levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro. Brain Res. 557:289-292.
8. BENITEZ-KING, G., L. HUERTA DELGADILLO, F. ANTON TAY (1993) Binding of tritium melatonin to calmodulin. Life Sci. 53:201-207.
9. BETTAHI, I., D. POZO, C. OSUNA, R.J. REITER, D. ACUÑA-CASTROVIEJO, J.M. GUERRERO (1996) Melatonin reduces nitric oxide synthase in rat hypothalamus. J. Pineal Res. 20:205-210.
10. BURTON, K. (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62:315-323.
11. CADET, J.L., M. KATZ, V. JAKSON-LEWIS, S. FAHN (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res. 476:10-15.
12. CARLBERG, C., I. WEISSENBERG (1995) The orphan receptor family RZR/ROR, melatonin and lipoxygenase: An unexpected relationship. J. Pineal Res. 18:121-128.
13. CHIUEH, C.C., S.J. HUANG, D.L. MURPHY (1994) Suppression of hydroxyl radical formation by MAO inhibitors: A novel possible neuroprotective mechanism in dopaminergic neurotoxicity. J. Neural Transm. 41P:189-196.
14. CHONCZYNSKI, P., N. SACCHI (1987) Single-step method of RNA isolation by a guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
15. COHEN, G., R. HEILLILA (1974) The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 250:2447-2452.
16. COLOTTA, F., N. POLENTARUTTI, M. SIRONI, A. MANTOVANI (1992) Expression and involvement of c-fos and c-jun proto-oncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267:18278-18283.
17. COLTON, C.A., F. PAGAN, J. SNELL, J.S. COLTON, A. CUMMINS, D.L. GILBERT (1995) Protection from oxidation enhances the survival of cultured mesencephalic neurons. Exp. Neurol. 132:54-61.
18. COSTA, E.J., R.H. LOPES, M.T. LAMY-FREUND (1995) Permeability of pure lipid bilayers to melatonin. J. Pineal. Res., 19:123-126.
19. DESOLE, M.S., L. SCIOLA, M.R. DELOGU, S. SIRCANA, R. MIGHELI (1996) Manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine induce apoptosis of PC12 cells. Neurosci. Lett. 209:193-196.
20. DRACHMAN, D.A. AND C.F. LIPPA (1992) The etiology of Alzheimers disease: the pathogenesis of dementia. Ann. N. Y. Acad. Sci. 648:176-186.
21. FERRARI, G., C.Y.I. YAN, L. GREENE (1995) N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15:2857-2866.
22. FREEMAN, R.F., S. ESTUS, E.M. JOHNSON JR. (1994) Analysis of cell-related gene expression in postmitotic neurons: selective induction of Cyclin DI during programmed cell death. Neuron 12:343-355.
23. FURUTA, S., H. HAYASHI, M. HIJIKATA, S. MIYAZAWA, T. OSUMI AND T. HASHIMOTO (1986) Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver catalase. Proc. Natl. Acad. Sci. U.S.A. 83:313-317.
24. GAVRIELI, Y., Y. SHERMAN, S.A. BEN-SASSON (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119:493-501.
25. GOTZ, M.D., A. FREYBERG, P. RIEDERER (1990) Oxidative stress: A role in the pathogenesis of Parkinson's disease. J. Neural Transm. 29:241-249.
26. GREENE, L., A.S. TISCHLER (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73:2424-2428.
27. GUNNING, P., P. PONTE, H. OKAYAMA, J. ENGEL, H. BLAU, L. KEDES (1983) Isolation and characterization of full-length cDNA for human alpha, beta and gamma actin have an amino-terminal cysteine that is subsequently removed. Mol. Cell Biol. 3:787-795.
28. HANSEN, M.B., S.E. NIELSEN, K. BERG (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210.
29. HEINTZ, N. (1993) Cell death and the cell cycle: a relationship between transformation and degeneration? Trends Biochem. Sci. 18:157-159.
30. HILL, B.T., D. BLASK (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF7) in culture. Cancer Res. 48:6121-6126.
31. Ho, Y.S., J.D. CRAPO (1987a) Nucleotide sequencing of cDNA coding for rat manganese-containing superoxide dismutase. Nucleic Acid Res. 15:10070.
32. Ho, Y.S., J.D. CRAPO (1987b) cDNA and deduced amino acid sequence of rat copper-zinc-containing superoxide dismutase. Nucleic Acid Res. 15:6746.
33. HUNG, H-C., E.H.Y. LEE (1996) The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP toxicity: Role of BDNF gene expression. Mol Brain Res. 41:16-26.
34. ICHITANY, Y., H. OKAMURA, Y. MATSUMOTO, I. NAGATSU, Y. IVATA (1991) Degeneration of the nigral dopamine neurons after 6-OHDA injection into the rat striatum. Brain Res. 549:350-353.
35. JAIN, A., J. MARTENSSON, E. STOLE, P.A.M. AULD, A. MEISTER (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. U.S.A. 88:1913-1917.
36. JESBERBER, J.A., J.S. RICHARDSON (1991) Oxygen free radicals and brain dysfunction. Int J. Neurosci. 57:1-17.
37. JONES, D.P., D.J. MCKONKEY, P. NICOTERA, S. ORRENIUS (1989) Calcium activated DNA fragmentation in rat liver nuclei. J. Biol. Chem. 264:6398-6403.
38. JOSEPH, R., W. LI, E. HAN (1992) Neuronal death, cytoplasmic calcium and internucleosomal DNA fragmentation: evidence for DNA fragments being released from cells. Mol. Brain Res. 17:70-76.
39. KOTLER, M., C. RODRIGUEZ, R.M. SAINZ, I. ANTOLIN, A. MENENDEZ-PELAEZ (1998) Melatonin increases mRNA for antioxidant enzymes in brain cortex. J. Pineal Res. in press.
40. LEZOUALC'H, F. SKUTELLA, M. WIDMANN, C. BEHL (1996) Melatonin prevents oxidative stress induced cell death in hippocampal cells. NeuroReport 7:2071-2077.
41. LOO, D.T., A. COPANI, C.J. PIKE, E.R. WHITTEMORE, A.J. WALENCEWICZ, C.W. COTMAN (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90:7951-7955.
42. MARTIN, J.B., M.F. BEAL (1992) Huntingtons disease and neurotoxins. Ann. N.Y. Acad. Sci. 648:169-175.
43. 2+ concentration. Arch. Biochem. Biophys. 269:365-370.
44. MELCHORRI, D., R.J. REITER, A.M. ATTIA, M. HARA, G. NISTICO (1995) Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:83-89.
45. MELDRUM, B., J. GARTHWAITE (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:379-387.
46. MENENDEZ-PELAEZ, A., R.J. REITER (1993) Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J. Pineal Res. 15:59-69.
47. MENENDEZ-PELAEZ, A., C. RODRIGUEZ, P. DOMINGUEZ (1991) 5-aminolevulinate synthase mRNA levels in the Harderian gland of Syrian hamsters: Correlation with porphyrin concentrations and regulation by androgens and melatonin. Mol. Cell. Endocrinol. 80:177-182.
48. MENENDEZ-PELAEZ, A., B. POEGGELER, R.J. REITER, L. BARLOW-WALDEN, M. PABLOS, D.X. TAN (1993) Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53:373-382.
49. MICHEL, P.P., F. HEFTY (1990) Toxicity of 6-hydroxidopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:428-435.
50. PAPPOLLA, M., M. SOS, R.A. OMAR, R.J. BICK, D.L.M. HICKSONBICK, R.J. REITER, S. EFTHIMIOPOULOS, N.K. ROBAKIS (1997) Melatonin prevents death of neuroblastoma cells exposed to Alzheimer's amyloid peptide. J. Neurosci. 17:1683-1690.
51. PERRY, T.L., V.W. YONG, R.M. CLAVIER, K. JONES, J.M. WRIGHT, J.G. FOULKS, R.A. WALL (1985) Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci. Lett. 60:109-114.
52. PIERI, C., M. MARRA, F. MORONI, R. DECCHIONI, F. MARCHESELLI (1994) Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:271-276.
53. PIERREFICHE G., G. TOPALL, G. COURBAIN, I. HENRIET, H. LABORIT (1993) Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80:211-223.
54. POZO, D., R.J. REITER, J.R. CALVO, J.M. GUERRERO (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 55:455-460.
55. RAMSAY, R.R., J. DADGAR, A. TREVOR, T.P. SINGER (1986) Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci. 39:581-588.
56. REITER, R.J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Res. 12:151-180.
57. REITER, R.J. (1992) The aging pineal gland and its physiological consequences. BioEssays 14:169-175.
58. REITER, R.J. (1995a) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:526-533.
59. REITER, R.J. (1995b) Oxygen radical detoxification processes during aging: The functional importance of melatonin. Aging Clin. Exp. Res. 7:340-351.
60. REITER, R.J. (1997) Antioxidant actions of melatonin. Adv. Pharmacol. 38:103-117.
61. REITER, R.J., M.I. PABLOS, T.T. AGAPITO, J.M. GUERRERO (1996) Melatonin in the context of the free radical theory of aging. Ann. N.Y. Acad. Sci. 286:362-378.
62. RUBIN, L.L., K.L. PHILPOTT, S.F. BROOKS (1993) The cell cycle and cell death. Curr. Biol. 3:391-394.
63. SAINZ, R.M., J.C. MAYO, H. URÍA, M. KOTLER, I. ANTOLÍN, C. RODRÍOUEZ, A. MENENDEZ-PELAEZ (1995) The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis of thymocytes. J. Pineal Res. 19:178-188.
64. SCHULZ, J.B., R.T. MATTEWS, M.M. MUQIT, S.E. BROWNE, M.F. BEAL (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:936-939.
65. SHELLARD, S.A., R.D. WHELAN, B.T. HIL (1989) Growth inhibitory and citotoxic effect of melatonin and its metabolites on human tumor cell lines in vitro. Br. J. Cancer 60: 288-295.
66. SHIDA, C.S., A.M.L. CASTRUCCI, M.T. LAMY-FREUND (1994) High melatonin solubility in aqueous medium. J. Pineal Res. 16:198-201.
67. SHULTS, C., T. KIMBER, A. ALTAR (1995) BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. NeuroReport 6:1109-1112.
68. SINET, P.M., R.E. HEIKKILA, G. COHEN (1980) Hydrogen peroxide production in rat brain in vivo. J. Neurochem. 34:1421-1428.
69. SOKOLOFF, L. (1996) The metabolism of the central nervous system in vivo. In: Handbook of Physiology-Neurophysiology. Field, J., H.W. Magoun, V.E. Hall, eds. American Physiological Society, Washington, Vol 3, pp. 1843-1864.
70. SPINA, M.B., S.P. SQUINTO, J. MILLER, R.M. LINDSAY, C. HYMAN (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methys-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59:99-106.
71. STADTMAN, E.R. (1992) Protein oxidation and aging. Science 257:1220-1224.
72. TAN, D.X., L.D. CHEN, B. POEGGELER, L.C. MANCHESTER, R.J. REITER (1993) Melatonin: A potent endogenous hydroxyl radical scavenger. Endocr. J. 1:57-60.
73. TAN, D.X., R.J. REITER, L.D. CHEN, B. POEGGELER, L.C. MANCHESTER, L. BARLOW-WALDEN (1994) Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15:215-218.
74. THIFFAULT, C., N. AUMONT, R. QUIRION, J. POIRIER (1995) Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65:2725-2733.
75. TIFFANY-CASTIGLIONI, E., J.R. PEREZ-POLO (1981) Stimulation of resistance to 6-hydroxidopamine in a human neuroblastoma cell line by nerve growth factor. Neurosci. Lett. 26:157-161.
76. TOMAC, A., E. LINDQVIST, L.F. H. LIN, S.O. OGREN, D. YOUNG, B.J. HOFFER, L. OLSON (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
77. TROY, M., D. DEROSSI, A. PROCHIANTZ, L.A. GREENE, L. SHELANSKI (1996) Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxinitrite pathway. J. Neurosci. 16:253-261.
78. TURSKI, L., K. BRESSLER, K.J. RETTIG, P.A. LOSCHMANN, H. Wachtel (1991) Protection of substantia nigra from MPP neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349:414-418.
79. WALKINSHAW, G., C.M. WATERS (1994) Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63:975-987.
80. WIESENBERG, I., M. MISSBACH, J.-P. KAHLEN, M. SCHRADER, C. CARLBERG (1995) Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23:327-333.
81. WU, R.M., D.L. MURPHY, C.C. CHIUEH (1996) Suppression of hydroxyl radical formation and protection of nigral neurons by 1-deprenyl (selegiline). Ann. N.Y. Acad. Sci. 786:379-390.
82. WYLLIE, A.M., J.F.R. KERR, A.R. CURRIE (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 58:251-301.
83. YOSHIMURA, S., S. TAKEKOSHI, K. WATANABE, Y. FUJII-KURIYAMA (1988) Determination of nucleotide sequence of cDNA coding rat glutathione peroxidase and diminished of the mRNA in selenium deficient rat liver. Biochem Biophys Res Commun 154:1024-1028.
84. ZIGMOND, M.J., E.M. STRICKER (1989) Animal models of Parkinsonism using selective neurotoxins: clinical and basic implications. Int. Rev. Neurobiol. 31:1-79.
85. ZUBER, M., A. ALPEROVITCH (1991) Maladie de Parkinson et facteurs environnementaux. Rev. Epidemiol. Sante Publique, 39:373-387.